Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Oct;12(10 HCC):e5871.
doi: 10.5812/hepatmon.5871. Epub 2012 Oct 28.

Coincidental occurrence of hepatocellular carcinoma and cholangiocarcinoma (collision tumors) after liver transplantation: a case report

Affiliations
Case Reports

Coincidental occurrence of hepatocellular carcinoma and cholangiocarcinoma (collision tumors) after liver transplantation: a case report

Waleed Al Hamoudi et al. Hepat Mon. 2012 Oct.

Abstract

Coincidental occurrence of hepatocellular carcinoma (HCC) and cholangiocarcinoma, known as "collision tumors", within a cirrhotic liver is rare. Herein, we report a case of liver transplantation (LT) in a patient with such collision tumors. Our patient was a 56-year-old woman with hepatitis C virus-related cirrhosis and 2 focal hepatic lesions, measuring 1.5 and 3 cm, in the liver segments 8 and 5, respectively. The lesion on segment 8 showed the typical radiological characteristics of HCC; however, the lesion in segment 5 showed an atypical vascular pattern and was closely associated with the inferior vena cava. Serum alpha-fetoprotein level was normal and serum carbohydrate antigen 19-9 (CA19-9) level was slightly elevated (63 U/mL); the extrahepatic spread of HCC was ruled out. The patient underwent an uneventful deceased-donor LT. Histopathological examination of the explant confirmed that the lesion on segment 8 was an HCC, but surprisingly, the lesion on segment 5 was found to be a cholangiocarcinoma. Six months after LT, the serum CA19-9 level was markedly elevated (255 U/mL), and the patient began experiencing abdominal pain. Magnetic resonance imaging showed enlarged hilar and paraaortic lymph nodes that were suggestive of metastases; histopathological analysis using ultrasound (US)-guided biopsy confirmed recurrent cholangiocarcinoma. Unfortunately, the patient died because of tumor recurrence 9 months after LT.Collision tumor resulting from the co-existence HCC and cholangiocarcinoma in a cirrhotic liver is rare and has a negative impact on the outcome of LT. Atypical vascular pattern and elevated serum CA19-9 levels are suggestive of such tumors; patients with these findings should undergo a targeted biopsy to rule out the coincidental occurrence of HCC and cholangiocarcinoma.

Keywords: Biopsy; CA19-9 Antigen; Hepatic Lesion; Recurrence.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Dynamic Computed Tomography (CT) Before Liver Transplantation
A) A 1.5-cm-size focal hepatic lesion with typical vascular pattern of hepatocellular carcinoma (HCC) in segment 8; B) A 3-cm-size focal hepatic lesion with atypical vascular pattern of HCC in segment
Figure 2
Figure 2. Histopathological Characteristics
A) The lesion in segment 8 showing hepatocellular carcinoma; B) The lesion in segment 5 showing cholangiocarcinoma (hematoxylin and eosin [H&E] staining; magnification × 20)
Figure 3
Figure 3. Magnetic Resonance Imaging (MRI) After Liver Transplantation Showing Enlarged Hilar and Paraaortic Lymph Nodes, Which Were Proven to be a Metastatic Cholangiocarcinoma

Similar articles

Cited by

References

    1. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208–36. doi: 10.1002/hep.20933. - DOI - PubMed
    1. Chen LD, Xu HX, Xie XY, Xie XH, Xu ZF, Liu GJ, et al. Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound. Eur Radiol. 2010;20(3):743–53. doi: 10.1007/s00330-009-1599-8. - DOI - PubMed
    1. Leoni S, Piscaglia F, Golfieri R, Camaggi V, Vidili G, Pini P, et al. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol. 2010;105(3):599–609. doi: 10.1038/ajg.2009.654. - DOI - PubMed
    1. Sherman M. The radiological diagnosis of hepatocellular carcinoma. Am J Gastroenterol. 2010;105(3):610–2. doi: 10.1038/ajg.2009.663. - DOI - PubMed
    1. Silva MA, Hegab B, Hyde C, Guo B, Buckels JA, Mirza DF. Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut. 2008;57(11):1592–6. doi: 10.1136/gut.2008.149062. - DOI - PubMed

Publication types

LinkOut - more resources